Get the Stockscreener App
1.22
0.00%
0.00
After Hours:
1.22
Pmv Pharmaceuticals Inc stock is traded at $1.22, with a volume of 150.74K.
It is up +0.00% in the last 24 hours and up +2.52% over the past month.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
See More
Previous Close:
$1.22
Open:
$1.23
24h Volume:
150.74K
Relative Volume:
0.37
Market Cap:
$64.92M
Revenue:
-
Net Income/Loss:
$-51.47M
P/E Ratio:
-1.22
EPS:
-1
Net Cash Flow:
$-47.50M
1W Performance:
+0.00%
1M Performance:
+2.52%
6M Performance:
+2.52%
1Y Performance:
-22.29%
1-Day Range:
$1.21
$1.25
1-Week Range:
$1.20
$1.29
52-Week Range:
$0.81
$1.84
Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile
Name
Pmv Pharmaceuticals Inc
Sector
Industry
Phone
(609) 642-6670
Address
400 ALEXANDER PARK DRIVE, PRINCETON
Compare PMVP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PMVP
Pmv Pharmaceuticals Inc
|
1.22 | 64.92M | 0 | -51.47M | -47.50M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-08-24 | Upgrade | Oppenheimer | Perform → Outperform |
| May-13-24 | Initiated | Craig Hallum | Buy |
| Apr-12-24 | Initiated | Jefferies | Buy |
| Dec-27-23 | Initiated | Ladenburg Thalmann | Buy |
| Mar-02-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Sep-22-21 | Upgrade | Goldman | Neutral → Buy |
| Aug-19-21 | Initiated | Oppenheimer | Perform |
| Aug-02-21 | Initiated | Guggenheim | Buy |
| Jul-29-21 | Initiated | H.C. Wainwright | Buy |
| Oct-20-20 | Initiated | BofA Securities | Buy |
| Oct-20-20 | Initiated | Cowen | Outperform |
| Oct-20-20 | Initiated | Evercore ISI | Outperform |
| Oct-20-20 | Initiated | Goldman | Neutral |
View All
Pmv Pharmaceuticals Inc Stock (PMVP) Latest News
How strong is PMV Pharmaceuticals Inc. stock balance sheet2026 world cup usa national team final young talents set piece tactics odds analysis preview - Улправда
PMV Pharmaceuticals (NASDAQ:PMVP) Stock Price Up 2.5%Here's What Happened - MarketBeat
Vani Commercials Limited May Be Forming Higher Low — Chartwatchers AlertTechnology Stock Trends & Investment Timing Techniques - bollywoodhelpline.com
Sector Rotation Brings Swan Defence and Heavy Industries Limited Into FocusVolatility Trading Techniques & Capital Allocation Recommendations - bollywoodhelpline.com
How resilient is PMV Pharmaceuticals Inc stock in market downturnsRate Hike & Weekly High Conviction Trade Ideas - moha.gov.vn
Is KEI Industries Limited in Accumulation Phase NowMarket Sentiment Report & Get Free Expert Trading Recommendations - bollywoodhelpline.com
Growth Report: Will PMV Pharmaceuticals Inc stock rally after Fed decisions2025 Biggest Moves & Long-Term Safe Investment Ideas - moha.gov.vn
How PMV Pharmaceuticals Inc. stock compares to growth peersMarket Growth Summary & Weekly Return Optimization Plans - Улправда
Sunrise Efficient Marketing Limited (543515) Quarterly Results Are Out2025 Price Momentum & Free Expert Verified Stock Movement Alerts - Bollywood Helpline
How PMV Pharmaceuticals Inc. stock responds to policy changesTrade Performance Summary & Community Trade Idea Sharing - Улправда
Aug Levels: How PMV Pharmaceuticals Inc. stock compares to growth peersJuly 2025 News Drivers & Community Consensus Stock Picks - Улправда
Fundamentals Check: What is the fair value of PMV Pharmaceuticals Inc. stock nowTrade Performance Summary & Long-Term Growth Portfolio Plans - DonanımHaber
Is PMV Pharmaceuticals Inc. stock ready for breakoutJuly 2025 Selloffs & Weekly High Return Opportunities - DonanımHaber
Is PMV Pharmaceuticals Inc. stock vulnerable to regulatory risksPortfolio Value Summary & Technical Buy Zone Confirmations - DonanımHaber
Will PMV Pharmaceuticals Inc. stock split attract more investors2025 Buyback Activity & Consistent Return Investment Signals - Улправда
How PMV Pharmaceuticals Inc. stock reacts to Fed rate cutsJuly 2025 Highlights & Target Return Focused Picks - Улправда
Trend Report: How PMV Pharmaceuticals Inc. stock reacts to Fed rate cutsCEO Change & Intraday High Probability Setup Alerts - Улправда
Will PMV Pharmaceuticals Inc. stock rally after Fed decisionsJuly 2025 Intraday Action & Weekly Sector Rotation Insights - Улправда
Institutions don’t gamble. Every trade is backed by:Sector ETF Performance & Access Free Risk Analysis Before You Invest - Bollywood Helpline
The Left Shoulder and Head formed clearly.Price Momentum Alerts & Outstanding Investment Trading - Bollywood Helpline
PMV Pharmaceuticals Earnings Notes - Trefis
PMV Pharmaceuticals announces updated rezatapopt monotherapy interim data - MSN
PMV Pharmaceuticals (NASDAQ:PMVP) Trading Down 1.7%Here's Why - MarketBeat
PMV Pharmaceuticals (NASDAQ:PMVP) Trading Down 1.7% – Here’s Why - Defense World
Will PMV Pharmaceuticals Inc. stock continue upward momentumPortfolio Gains Report & Real-Time Sentiment Analysis - Newser
PMV Pharmaceuticals (NASDAQ:PMVP) versus Aurinia Pharmaceuticals (NASDAQ:AUPH) Financial Comparison - Defense World
Why PMV Pharmaceuticals Inc. stock is a must watch in 2025Trade Risk Summary & Safe Entry Zone Identification - newser.com
Why PMV Pharmaceuticals Inc. stock appeals to analysts2025 Retail Activity & Precise Swing Trade Entry Alerts - newser.com
Contrasting PMV Pharmaceuticals (NASDAQ:PMVP) & Kiora Pharmaceuticals (NASDAQ:KPRX) - Defense World
Is PMV Pharmaceuticals Inc. stock poised for growth2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - newser.com
How rising interest rates impact PMV Pharmaceuticals Inc. stockPortfolio Profit Report & Reliable Price Breakout Alerts - newser.com
Will PMV Pharmaceuticals Inc. stock outperform Dow Jones index2025 Price Targets & Real-Time Price Movement Reports - newser.com
Will PMV Pharmaceuticals Inc. stock benefit from commodity pricesCEO Change & Growth Oriented Trading Recommendations - newser.com
Is PMV Pharmaceuticals Inc. stock safe for conservative investorsJuly 2025 Momentum & Free High Return Stock Watch Alerts - newser.com
Is PMV Pharmaceuticals Inc. building a consolidation base2025 Volatility Report & Stock Portfolio Risk Control - newser.com
Pmv Pharmaceuticals Inc Stock (PMVP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Pmv Pharmaceuticals Inc Stock (PMVP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 10% Owner |
Oct 23 '25 |
Sale |
1.52 |
1,000,000 |
1,520,000 |
4,975,291 |
2.52%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):